<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Watson Laboratories, Inc.; Withdrawal of Approval of an Abbreviated New Drug Application for Oxycodone Hydrochloride and Ibuprofen Tablets</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Watson Laboratories, Inc.; Withdrawal of Approval of an Abbreviated New Drug Application for Oxycodone Hydrochloride and Ibuprofen Tablets</h1>
    <p class="timestamp">Published: 2020-08-03 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) is withdrawing approval of an abbreviated new drug application (ANDA) for oxycodone hydrochloride and ibuprofen tablets. The basis for the withdrawal is that the holder of the ANDA has repeatedly failed to submit the required data to support a finding of bioequivalence for this ANDA. The holder of the ANDA has waived its opportunity for a hearing.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2020-16784</p>
    <p><strong>Publication Date:</strong> 2020-08-03</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2020/08/03/2020-16784/watson-laboratories-inc-withdrawal-of-approval-of-an-abbreviated-new-drug-application-for-oxycodone">https://www.federalregister.gov/documents/2020/08/03/2020-16784/watson-laboratories-inc-withdrawal-of-approval-of-an-abbreviated-new-drug-application-for-oxycodone</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2020-16784</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
